ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 128 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,049,000 | -33.5% | 142,706 | -9.1% | 0.00% | 0.0% |
| Q4 2020 | $3,080,000 | +58.1% | 156,913 | +4.4% | 0.00% | 0.0% |
| Q3 2020 | $1,948,000 | +15.1% | 150,300 | +29.3% | 0.00% | 0.0% |
| Q2 2020 | $1,693,000 | +73.6% | 116,200 | +1.5% | 0.00% | +100.0% |
| Q1 2020 | $975,000 | -44.5% | 114,519 | +7.4% | 0.00% | -50.0% |
| Q4 2019 | $1,756,000 | +116.8% | 106,619 | +85.9% | 0.00% | +100.0% |
| Q3 2019 | $810,000 | +10.7% | 57,345 | +57.5% | 0.00% | 0.0% |
| Q2 2019 | $732,000 | -47.2% | 36,400 | +4.3% | 0.00% | -50.0% |
| Q1 2019 | $1,387,000 | -20.5% | 34,900 | -30.5% | 0.00% | 0.0% |
| Q4 2018 | $1,745,000 | -9.0% | 50,240 | +8.4% | 0.00% | 0.0% |
| Q3 2018 | $1,917,000 | +10.2% | 46,366 | -2.0% | 0.00% | 0.0% |
| Q2 2018 | $1,739,000 | -21.1% | 47,329 | -16.2% | 0.00% | -33.3% |
| Q1 2018 | $2,203,000 | – | 56,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 2,932,865 | $48,304,000 | 3.48% |
| Camber Capital Management LP | 2,950,000 | $48,587,000 | 2.47% |
| Trellus Management Company, LLC | 87,873 | $1,447,000 | 2.42% |
| Redmile Group, LLC | 4,648,570 | $76,562,000 | 1.83% |
| Baupost Group | 8,308,900 | $136,848,000 | 1.51% |
| MAVERICK CAPITAL LTD | 4,958,431 | $81,665,000 | 1.19% |
| Artal Group S.A. | 1,750,000 | $28,823,000 | 1.11% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 175,000 | $2,882,000 | 0.36% |
| 12 West Capital Management LP | 158,700 | $2,614,000 | 0.16% |
| WASATCH ADVISORS LP | 1,101,103 | $18,135,000 | 0.15% |